机构地区:[1]北京中医药大学房山医院肺病三科,北京102400 [2]北京中医药大学房山医院治未病科,北京102400 [3]北京中医药大学第三附属医院急诊科,北京100029 [4]北京中医药大学房山医院内科,北京102400 [5]北京中医药大学房山医院肿瘤科,北京102400 [6]北京中医药大学房山医院糖尿病科,北京102400
出 处:《中国医药导报》2019年第15期124-127,共4页China Medical Herald
基 金:北京市科技计划课题(Z161100000516121)
摘 要:目的观察“补益肺气法”联合针刺治疗肺气虚型煤工尘肺病患者的治疗效果。方法选取2016年1月~2018年1月北京中医药大学房山医院肺病三科就诊的肺气虚型煤工尘肺病患者88例,采用随机数字表法将其分为治疗组及对照组,每组44例。因不能配合治疗等原因,最后共81例参与统计,治疗组41例,对照组40例。对照组给予患者氧疗、口服盐酸氨溴索片30 mg,3次/d;治疗组在对照组的治疗基础上,给予患者补益肺气中药口服及针刺治疗(取穴:双侧肺俞、合谷、丰隆)。比较冶疗前、治疗12周后及治疗结束4周后两组患者咳嗽、气短视觉模拟评分;比较治疗12周后6分钟步行试验和肺功能变化及SF-36评分变化情况。结果治疗12周及治疗结束4周后,两组咳嗽、气短视觉模拟评分均较治疗前降低(P < 0.05),且治疗组低于对照组(P < 0.05)。两组治疗12周后,其6分钟步行试验步行距离均长于治疗前(P < 0.05);且治疗组长于对照组(P < 0.05)。两组治疗12周后,其肺功能中FEV1、FEV1/FVC均较治疗前升高(P < 0.05),且两组差异无统计学意义(P > 0.05)。两组治疗12周后SF-36评分均较治疗前升高(P < 0.05),且治疗组高于对照组(P < 0.05)。结论“补益肺气法”联合针刺治疗肺气虚型煤工尘肺病患者,在改善患者咳嗽、气短症状及6分钟步行试验、生存质量方面优于单纯给予西药治疗。Objective To observe the therapeutic effect of "tonifying lung-qi" combined with acupuncture on patients with lung-qi deficiency type coal worker′s pneumoconiosis. Methods Eighty-eight patients with lung-qi deficiency type coal worker′s pneumoconiosis who were admitted to the Department of Pulmonary Diseases, Fangshan Hospital, Beijing University of Chinese Medicine from January 2016 to January 2018 were randomly divided into treatment group and control group, with 44 cases in each group. Because of the inability to cope with treatment and other reasons, a total of 81 cases participated in the statistics, 41 cases in the treatment group and 40 cases in the control group. The control group was given oxygen therapy and Ambroxol Hydrochloride Tablets 30 mg three times a day, while the treatment group was given oral and acupuncture treatment of traditional Chinese medicine for tonifying lung-qi (acupoint selection: bilateral Feishu, Hegu, Fenglong) on the basis of the treatment of the control group. The cough and shortness of breath visual analogue scores were compared between the two groups before treatment, after 12 weeks of treatment and 4 weeks after the end of treatment. The 6-minute walking test and the changes of pulmonary function and SF-36 scores were compared after 12 weeks of treatment. Results After 12 weeks of treatment and 4 weeks after the end of treatment, the cough and shortness of breath visual analogue scores of the two groups were lower than those before treatment (P < 0.05), and the treatment group was lower than that of the control group (P < 0.05). After 12 weeks of treatment, the 6-minute walking distances of the two groups were greater than that before treatment (P < 0.05), and the treatment group was longer than that of the control group (P < 0.05). After 12 weeks of treatment, FEV1 and FEV1/FVC in lung functions of the two groups were higher than those before treatment (P < 0.05), and there was no significant difference between the two groups (P > 0.05). After 12 weeks of treatment, the
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...